• Home
  • News
    • Editorial
    • MD(e)B(unker)
    • Related Researches
      • Di Bella's Foundation
      • 1960-1969
      • 1970-1979
      • 1980-1989
      • 1990-1999
      • 2000-2009
      • 2010-2019
      • 2020-2029
    • Science news
    • Scientific Documentation
  • About us...
    • Biography
    • Bibliography
  • The Method
    • Di Bella's Method!
    • 1998 Trial!
  • Media
    • Video Publications
    • News-PapersNews-Papers
      • Press
    • TestimonialTestimonial
      • Testimonies
    • Video GalleryVideo Gallery
      • Congresses
      • Video Testimonies
      • TV & C.
  • Case History
    • Medical reports
      • Lung
      • Lymphomas
        • Non-Hodgkin Lymphomas
        • Hodgkin Lymphomas
      • Mediastinum
      • Mesothelioma
      • Myeloma
      • Pancreas
      • Scientific Publications
  • F.A.Q.
  • Useful Links
    • User Side
      • Vademecum
    • CouponChief - Resources for Cancer Patients
  • Contact Us
Home page   News   Related Researches   2010-2019  
Title Created Date
Antiproliferative effect of growth hormone-releasing hormone (GHRH) antagonist on ovarian cancer cells through the EGFR-Akt pathway 26 December 2013
Effects of growth hormone-releasing hormone and its agonistic and antagonistic analogs in cancer and non-cancerous cell lines 26 December 2013
Molecular mechanisms of melatonin's inhibitory actions on breast cancers 11 December 2013
Therapeutic actions of melatonin on gastrointestinal cancer development and progression 04 December 2013
All trans retinoic acid nanodisks enhance retinoic acid receptor mediated apoptosis and cell cycle arrest in mantle cell lymphoma 03 December 2013
Inhibitory effect of somatostatin analogue octreotide on the expression of p53 and Ras in human gastric cancer 02 December 2013
New agonist- and antagonist-based treatment approaches for advanced prostate cancer 29 November 2013
Somatostatin analogue inhibits the mobility of prostate carcinoma cells: a new therapeutic method for advanced prostate carcinoma 29 November 2013
Treatment of unresectable skull base meningiomas with somatostatin analogs 29 November 2013
Expression of somatostatin receptors, dopamine D₂ receptors, noradrenaline transporters, and vesicular monoamine transporters in 52 pheochromocytomas and paragangliomas 27 November 2013
Display # 

Page 168 of 172

  • Start
  • Prev
  • 163
  • 164
  • 165
  • 166
  • 167
  • 168
  • 169
  • 170
  • 171
  • 172
  • Next
  • End

Search

Follow us...

Latest

  • Melatonin: An Anti-Tumor Agent in Hormone-Dependent Cancers
  • Updated perspectives on vitamin D deficiency, screening, supplementation and clinical guidance
  • Melatonin: an inhibitor of breast cancer
  • All-trans retinoic acid suppresses CD8+ T-cell terminal exhaustion and potentiates anti-PD-1 therapy in glioblastoma
  • Retinoid-induced suppression of squamous cell differentiation in human oral squamous cell carcinoma xenografts (line 1483) in athymic nude mice
  • Effect of oral melatonin on sleep quality, fatigue, and caregiver sleep perception in patients with head and neck cancer: A randomized double-blind placebo-controlled trial
  • Mechanisms Underlying Tumor Suppressive Properties of Melatonin
  • Vitamin D supplementation is associated with reduced risk of hepatobiliary malignancy in patients with primary sclerosing cholangitis
  • Growth-inhibitory activity of melatonin on human androgen-independent DU 145 prostate cancer cells
  • A case control study to determine the frequency of vitamin d deficiency in carcinoma breast in females of local population of Rawalpindi and Islamabad area
  • In vitro and in vivo antitumor activity of melatonin receptor agonists
  • Proteoformics-driven new concept of human growth hormone in clinical endocrinology
  • The role of melatonin in colorectal cancer treatment: a comprehensive review
  • The Role of Melatonin in Colorectal Cancer
  • Ameliorative effects of melatonin on radiotherapy-induced apoptotic and inflammatory responses in rat parotid gland
  • The role of melatonin in immuno-enhancement: potential application in cancer
  • Circulating neuroendocrine markers in patients with prostate carcinoma
  • Somatostatin and the treatment of cancer

Most Read

  • The Di Bella Method (DBM)
  • About melatonin - 1996
  • All-trans-retinoic acid and cancer
  • Biography
  • Chronic Lymphocytic Leukemia: 4 patients, long-lasting remission
  • Somatostatin in oncology, the overlooked evidences
  • The Di Bella Method Increases by the 30% the survival rate for Pancreas tumors and for this reason should be proposed as first line therapy for this type of cancer
  • Treatment of Low-grade Non-Hodgkin’s Lymphomas at Advanced Stage
  • How effective is chemo therapy?
  • Complete objective response to biological therapy of plurifocal breast carcinoma
  • Bibliography
  • Large B-cells Non-Hodgkin's Lymphoma, Stage IV-AE: a Case Report
  • Non-Hodgkin's Lymphoma, Stage III-B-E: a Case Report
  • Vademecum
  • Frequently Asked Questions
  • Declaration recommends eliminate the use of Impact factor for research evaluation
  • Non–Small-Cell Lung Cancer Patients with Low Performance Status: study on 28 patients
  • Breast cancer: study on 122 cases. The Di Bella Method (DBM) improved survival, objective response and performance status in a retrospective observational clinical study on 122 cases of breast cancer